FDA Might Have Plan to Continue Drug Approvals if Shutdown Continues

FDA Might Have Plan to Continue Drug Approvals if Shutdown Continues

Source: 
BioSpace
snippet: 

As the federal government shutdown moves past 35 days, the U.S. Food and Drug Administration (FDA) has kept some of its activities in operation, such as inspecting manufacturing plants and screening drug imports. Drug approvals are funded by review fees. At the moment, that funding is expected to run out on February 17 or, if the agency scrimps, perhaps as long as February 28.